Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2015
At a glance
- Drugs Aramchol (Primary)
- Indications Cholelithiasis
- Focus Proof of concept; Therapeutic Use
- Sponsors Galmed Pharmaceuticals
- 02 Oct 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
- 13 May 2015 According to a Galmed media release, the enrolment pace of the trial has tracked significantly slower than anticipated. Therefore, the company decided to expand the trial into 3 additional centers. However, enrolment has still continued to disappoint. Therefore, the company has filed a request with the principal investigator to cease enrollment in the underperforming center. The company is taking this opportunity to reexamine the study design in order to achieve a better recruitment.
- 05 Jan 2015 New trial record